Specialty Focus Recordati España operates in Specialty & Primary Care across multiple therapeutic areas including urology, gastroenterology, pediatrics, psychiatry, cardiology and gynecology, presenting opportunities to cross-sell and expand portfolio within Spain’s hospital and clinic networks.

Integrated Operations With end-to-end capabilities from clinical development and manufacturing to commercialization and licensing, there is potential to partner on local R&D collaborations, contract manufacturing, or regional licensing deals to accelerate time-to-market for new therapies.

Manufacturing Footprint Having a own manufacturing plant and a centralized Madrid base with Zaragoza operations suggests capacity and supply chain reliability for new product launches, both in primary care and specialty segments, appealing to distributors seeking proven, in-country production.

Financial Scale Revenue in the 10 to 25 million USD range indicates a mid-market footprint with room for growth through expanded product lines, co-promotion arrangements, and partnerships with larger pharma for market expansion or portfolio augmentation.

Geographic & Market Fit As the Spanish arm of a global group with a long-standing pharmaceutical heritage, Recordati España is well-positioned to leverage international licensing opportunities and regulatory know-how to introduce rare disease and specialty products into the Spanish market.